Qlucore AB (publ) - Asset Resilience Ratio

Latest as of December 2011: 0.17%

Qlucore AB (publ) (NOVKAN) has an Asset Resilience Ratio of 0.17% as of December 2011. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Skr67.00K

≈ $7.21K USD Cash + Short-term Investments

Total Assets

Skr39.74 Million

≈ $4.28 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2010–2011)

This chart shows how Qlucore AB (publ)'s Asset Resilience Ratio has changed over time. See NOVKAN free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.

Liquid Assets Composition Over Time

This chart breaks down Qlucore AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Qlucore AB (publ) market cap and net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr0.00	0%
Short-term Investments	Skr67.00K	0.17%
Total Liquid Assets	Skr67.00K	0.17%

Asset Resilience Insights

Limited Liquidity: Qlucore AB (publ) maintains only 0.17% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Qlucore AB (publ) Industry Peers by Asset Resilience Ratio

Compare Qlucore AB (publ)'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Samsung Biologics Co Ltd KO:207940	Biotechnology	5.66%
Revolution Medicines Inc NASDAQ:RVMD	Biotechnology	65.10%
Abivax SA PA:ABVX	Biotechnology	2.34%
Asymchem Laboratories Tian Jin Co Ltd SHE:002821	Biotechnology	5.07%
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	43.36%
SOLENO THERAPEUT. DL-001 F:6XC	Biotechnology	41.74%
REMEGEN CO. LTD YC 1 F:REG	Biotechnology	16.77%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Annual Asset Resilience Ratio for Qlucore AB (publ) (2010–2011)

The table below shows the annual Asset Resilience Ratio data for Qlucore AB (publ).

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2011-12-31	0.17%	Skr67.00K ≈ $7.21K	Skr39.74 Million ≈ $4.28 Million	-3.40pp
2010-12-31	3.57%	Skr500.00K ≈ $53.81K	Skr14.01 Million ≈ $1.51 Million	--

pp = percentage points

About Qlucore AB (publ)

ST:NOVKAN USA Biotechnology

Market Cap

$326.04K

Skr3.03 Million SEK

Market Cap Rank

#31072 Global

#6200 in USA

Share Price

Skr0.03

Change (1 day)

-43.95%

52-Week Range

Skr0.03 - Skr0.23

All Time High

Skr0.23